NNVC nanoviricides.com: מקדם חוב לטווח ארוך להון

NanoViricides, Inc. (NNVC) maintains investor interest through its reputation as a leading developer of nanoprotection against viruses. Long-term credit leverage illustrates this trend, where 0.00 determines the current status of the parameter. The business valuation relies on a patent-protected platform, while management flexibility is ensured by the full outsourcing of production and testing, eliminating redundant capital expenditures.

Investors must assess the debt load of NanoViricides, Inc. (NNVC) to minimize the risk of capital loss. The absence of commercial products and a reliance on external financing leave the company vulnerable. The trend of the long-term debt-to-equity ratio reflects the proportion of loans with maturities exceeding one year relative to shareholders' equity. This indicator measures the degree of financial leverage and dependence on borrowed funds. A low debt level confirms the business's temporary stability in the absence of revenue.